Immunovia seeks Medicare coverage review for PancreaSure pancreatic cancer blood test

Bitget2026/09/28 12:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Immunovia filed a request for a new Medicare Local Coverage Determination seeking coverage of its PancreaSure pancreatic cancer blood test.
The submission starts a multi-step review by a Medicare Administrative Contractor that could lead to a final coverage decision.
Coverage would expand access among beneficiaries aged 65+, a key target population for high-risk pancreatic cancer surveillance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovia AB published the original content used to generate this news brief on September 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Immunovia seeks Medicare coverage review for PancreaSure pancreatic cancer blood test

You may also like

Crypto prices